Skip to main content

Table 1 Impact of adjuvant chemotherapy on reducing annual odds of recurrence and death

From: Dose-dense adjuvant chemotherapy for primary breast cancer

Comparison (n) Recurrence Death
CMF versus nil (8150) +24 ± 3 +14 ± 4
CMF+ versus nil (3218) +20 ± 5 +15 ± 5
Anthracyclines+ versus CMF (6950) +12 ± 4 +11 ± 5
Longer versus shorter (6104) +7 ± 4 -1 ± 5
  1. Values are expressed as percentage ± standard deviation. Data from Early Breast Cancer Trialists' Collaborative Group [3]. CMF, cyclophosphamide, methotrexate and 5-fluorouracil.